Compounds for the treatment of Clostridium difficile associated disease

Disclosed are compounds of formula (I): and pharmaceutically acceptable N-oxides, salts, hydrates, solvates, complexes, bioisosteres, metabolites, and prodrugs thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.

Saved in:
Bibliographic Details
Main Authors SUDLOW LAUREN JAYNE, WREN STEPHEN PAUL, VAN WELL RENATE MARIA, JOHNSON PETER DAVID, DORGAN COLIN RICHARD, WILSON FRANCIS XAVIER, VICKERS RICHARD JOHN
Format Patent
LanguageEnglish
Published 08.03.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disclosed are compounds of formula (I): and pharmaceutically acceptable N-oxides, salts, hydrates, solvates, complexes, bioisosteres, metabolites, and prodrugs thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.
AbstractList Disclosed are compounds of formula (I): and pharmaceutically acceptable N-oxides, salts, hydrates, solvates, complexes, bioisosteres, metabolites, and prodrugs thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.
Author VICKERS RICHARD JOHN
WILSON FRANCIS XAVIER
DORGAN COLIN RICHARD
SUDLOW LAUREN JAYNE
JOHNSON PETER DAVID
VAN WELL RENATE MARIA
WREN STEPHEN PAUL
Author_xml – fullname: SUDLOW LAUREN JAYNE
– fullname: WREN STEPHEN PAUL
– fullname: VAN WELL RENATE MARIA
– fullname: JOHNSON PETER DAVID
– fullname: DORGAN COLIN RICHARD
– fullname: WILSON FRANCIS XAVIER
– fullname: VICKERS RICHARD JOHN
BookMark eNqNyjsKAjEURuEUWvjaw92AoGOh0xp89Go9hMkfDCS5IffO_rVwAVYHPs7SzAoXLMzNcq48FS8UuJG-QdrgNKMocSCbWLRFH6dMPoYQx5hAToTH6BT-iwInWJt5cEmw-XVl6Hp52vsWlQdIdSMKdHg9-u542vX7c3f4Y_kATg412w
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US9278091B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US9278091B23
IEDL.DBID EVB
IngestDate Fri Jul 19 12:47:41 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US9278091B23
Notes Application Number: US201514620902
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160308&DB=EPODOC&CC=US&NR=9278091B2
ParticipantIDs epo_espacenet_US9278091B2
PublicationCentury 2000
PublicationDate 20160308
PublicationDateYYYYMMDD 2016-03-08
PublicationDate_xml – month: 03
  year: 2016
  text: 20160308
  day: 08
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies SUMMIT THERAPEUTICS PLC
RelatedCompanies_xml – name: SUMMIT THERAPEUTICS PLC
Score 3.0240474
Snippet Disclosed are compounds of formula (I): and pharmaceutically acceptable N-oxides, salts, hydrates, solvates, complexes, bioisosteres, metabolites, and prodrugs...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Compounds for the treatment of Clostridium difficile associated disease
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160308&DB=EPODOC&locale=&CC=US&NR=9278091B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-L8Ig_St-L6mfahCG1Xh-A23Cp7G_1IoDDbYTv8972ErvqibyGBIzn45e5yl_sBPFDN1HlGM5VyqqummyRq6lpMFcGFxQ2qpUwWyE7tSWy-rKxVD4r9XxjZJ_RLNkdERGWI90be19ufR6xQ1lbWj2mBU9VTtPRCpY2OBWfyyFFC3xvPZ-EsUILAixfK9M1zdeqgafTxtj5AL5oKMIzfffEpZfvbokSncDhHYWVzBj1WDuA42BOvDeDotc1347CFXn0OzwK5ggOpJuhnEvTbSFckTipOgk0lKDjyYvdBBOsJStgwkrTaZzlpUzEXQKLxMpiouKN1d_p1vOj2blxCv6xKdgUksXnCcs3kLkMMZtxhNM912xjlpss1jQ9h-KeY63_WbuBEqFFWWTm30G8-d-wOzW6T3kuFfQOJjYkm
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokb87IPZ2yIbG90eFhO24VQYRMDwRvbRJiSwERnx3_fajOmLvjVtcmkv-fXuetf7ATxQzdB5QhOVcqqrhh1FamybTBXBhck7VIuZLJANu8HMeJ2b8xos939hZJ_QL9kcERGVIN4LeV9vfh6xPFlbuX2MlziVP_WnjqeU0bHgTG5bitdz_PHIG7mK6zqziRK-O7ZOLTSNPbytD9DDpgIM_kdPfErZ_LYo_RM4HKOwrDiFGsua0HD3xGtNOBqW-W4cltDbnsGzQK7gQNoS9DMJ-m2kKhInOSfuKhcUHOlytyaC9QQlrBiJSu2zlJSpmHMgfX_qBiruaFGdfjGbVHvvXEA9yzN2CSTq8oilmsFthhhMuMVomurdTjs1bK5pvAWtP8Vc_bN2D41gOhwsBi_h2zUcC5XKiivrBurF547dogku4jupvG8j1YwZ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Compounds+for+the+treatment+of+Clostridium+difficile+associated+disease&rft.inventor=SUDLOW+LAUREN+JAYNE&rft.inventor=WREN+STEPHEN+PAUL&rft.inventor=VAN+WELL+RENATE+MARIA&rft.inventor=JOHNSON+PETER+DAVID&rft.inventor=DORGAN+COLIN+RICHARD&rft.inventor=WILSON+FRANCIS+XAVIER&rft.inventor=VICKERS+RICHARD+JOHN&rft.date=2016-03-08&rft.externalDBID=B2&rft.externalDocID=US9278091B2